Redeye: Doro - Same ol’ situation in phones … but Care is appealing

Mon, Oct 22, 2018 07:34 CET

The previous trends for Doro with stronger EBIT and negative underlying sales growth continued in Q3. We have lately become a lot more optimistic towards the future market prospects for Care, most notably related to the GreatCall bid. However, we see a risk that the traditional phones business could continue to weigh on the total.

Read more in our new research update: http://bit.ly/2J81OmJ

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/